Los puntos clave no están disponibles para este artículo en este momento.
The synthesis, luminescence, and electrochemical properties of the Ce(III) compound, (C5Me5)2(2,6-iPr2C6H3O)Ce(THF), 1, were investigated. Based on the electrochemical data, treatment of 1 with CuX (X = Cl, Br, I) results in the formation of the corresponding Ce(IV) complexes, (C5Me5)2(2,6-iPr2C6H3O)Ce(X). Each complex has been characterized using NMR, IR, and UV–vis spectroscopy as well as structurally determined using X-ray crystallography. Additionally, the treatment of (C5Me5)2(2,6-iPr2C6H3O)Ce(Br) with AgF results in the formation of the putative (C5Me5)2(2,6-iPr2C6H3O)Ce(F). The electronic structure of these Ce(IV)–X complexes was investigated by bond analyses and the Ce(IV)–F moiety using quantum chemistry NMR calculations.
Gremillion et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: